Ledger.Open graph →
SEC Form D · filed December 21, 2020

Reneo Pharmaceuticals, Inc

Offering
$94.8M
Sold
$47.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (31)

Michael Grey · San Diego, CADirectorLon Cardon, Ph.D · San Diego, CADirectorNiall O'Donnell, Ph.D · San Diego, CADirectorJohan Kordel, Ph.D · San Diego, CADirectorAlejandro Dorenbaum, M.D · San Diego, CAExecEd Mathers · San Diego, CADirectorWendy Johnson · San Diego, CAExecGregory Flesher · San Diego, CAExec · DirectorKenneth Harrison · San Diego, CADirectorMarco Strub · VANCOUVER, British Columbia, CanadaExecRosalinda Mendoza · Tieton, WADirectorBrian Bower · VANCOUVER, British Columbia, CanadaExecJohn Anderson · VANCOUVER, British Columbia, CanadaDirectorRakesh Patel · VANCOUVER, British Columbia, CanadaDirectorElizabeth Mendoza · Tieton, WADirectorJonathan Gazdak · New York, NYDirectorBali Muralidhar · SAN FRANCISCO, CADirectorStacey Seltzer · Milwaukee, WIDirectorMike Cruse · San Diego, CAExecDorrell P. Hinshaw · Solana Beach, CADirectorJean P. Balgrosky · Solana Beach, CADirectorSamir P. Damani · Solana Beach, CADirectorKyle P. Williams · Solana Beach, CADirectorDavid M. Stott · CHICAGO, ILDirectorChad S. Alfeld · SIMSBURY, CTExecTina E. St. Pierre · SIMSBURY, CTExecGregory Flesher · San Diego, CAExec · DirectorKenneth Harrison · San Diego, CADirectorBali Muralidhar · SAN FRANCISCO, CADirectorStacey Seltzer · Milwaukee, WIDirectorMike Cruse · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗